A new trading day began on Friday, with Monte Rosa Therapeutics Inc (NASDAQ: GLUE) stock price down -5.38% from the previous day of trading, before settling in for the closing price of $13.01. GLUE’s price has ranged from $3.50 to $13.59 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -41.09%. Meanwhile, its annual earnings per share averaged 77.47%. With a float of $38.52 million, this company’s outstanding shares have now reached $61.79 million.
Monte Rosa Therapeutics Inc (GLUE) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Monte Rosa Therapeutics Inc is 40.85%, while institutional ownership is 77.68%. The most recent insider transaction that took place on Jun 03 ’25, was worth 9,174. In this transaction Principal Accounting Officer of this company sold 2,062 shares at a rate of $4.45, taking the stock ownership to the 23,732 shares. Before that another transaction happened on Mar 24 ’25, when Company’s Director bought 10,000 for $5.84, making the entire transaction worth $58,383. This insider now owns 10,000 shares in total.
Monte Rosa Therapeutics Inc (GLUE) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.27 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 77.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.58% during the next five years compared to -41.09% drop over the previous five years of trading.
Monte Rosa Therapeutics Inc (NASDAQ: GLUE) Trading Performance Indicators
Here are Monte Rosa Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.42. Likewise, its price to free cash flow for the trailing twelve months is 5.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.31, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Monte Rosa Therapeutics Inc (GLUE)
Looking closely at Monte Rosa Therapeutics Inc (NASDAQ: GLUE), its last 5-days average volume was 0.88 million, which is a jump from its year-to-date volume of 0.84 million. As of the previous 9 days, the stock’s Stochastic %D was 61.21%.
During the past 100 days, Monte Rosa Therapeutics Inc’s (GLUE) raw stochastic average was set at 86.48%, which indicates a significant increase from 72.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.97 in the past 14 days, which was higher than the 0.46 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.43, while its 200-day Moving Average is $5.95. However, in the short run, Monte Rosa Therapeutics Inc’s stock first resistance to watch stands at $13.15. Second resistance stands at $13.99. The third major resistance level sits at $14.62. If the price goes on to break the first support level at $11.69, it is likely to go to the next support level at $11.06. Should the price break the second support level, the third support level stands at $10.22.
Monte Rosa Therapeutics Inc (NASDAQ: GLUE) Key Stats
With a market capitalization of 801.60 million, the company has a total of 61,759K Shares Outstanding. Currently, annual sales are 75,620 K while annual income is -72,700 K. The company’s previous quarter sales were 23,190 K while its latest quarter income was -12,300 K.
